1079 related articles for article (PubMed ID: 35414025)
1. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
2. Targeting regulated cell death with plant natural compounds for cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death, and necroptosis.
Yang Y; Chen Y; Wu JH; Ren Y; Liu B; Zhang Y; Yu H
Phytother Res; 2023 Apr; 37(4):1488-1525. PubMed ID: 36717200
[TBL] [Abstract][Full Text] [Related]
3. Regulated cell death (RCD) in cancer: key pathways and targeted therapies.
Peng F; Liao M; Qin R; Zhu S; Peng C; Fu L; Chen Y; Han B
Signal Transduct Target Ther; 2022 Aug; 7(1):286. PubMed ID: 35963853
[TBL] [Abstract][Full Text] [Related]
4. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets.
Qin R; You FM; Zhao Q; Xie X; Peng C; Zhan G; Han B
J Hematol Oncol; 2022 Sep; 15(1):133. PubMed ID: 36104717
[TBL] [Abstract][Full Text] [Related]
5. Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis.
Liu W; Jin W; Zhu S; Chen Y; Liu B
Drug Discov Today; 2022 Feb; 27(2):612-625. PubMed ID: 34718209
[TBL] [Abstract][Full Text] [Related]
6. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms.
Li R; Wu Y; Li Y; Shuai W; Wang A; Zhu Y; Hu X; Xia Y; Ouyang L; Wang G
Eur J Med Chem; 2024 Feb; 265():116040. PubMed ID: 38142509
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics.
Zhang H; Zhang J; Luan S; Liu Z; Li X; Liu B; Yuan Y
Int J Biol Sci; 2023; 19(12):3831-3868. PubMed ID: 37564206
[TBL] [Abstract][Full Text] [Related]
8. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential.
Zhang Y; Zhou X
Biomed Pharmacother; 2024 Jun; 175():116667. PubMed ID: 38703504
[TBL] [Abstract][Full Text] [Related]
9. Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy.
Ke B; Tian M; Li J; Liu B; He G
Med Res Rev; 2016 Nov; 36(6):983-1035. PubMed ID: 27357603
[TBL] [Abstract][Full Text] [Related]
10. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
11. Regulated cell death in cancer: from pathogenesis to treatment.
Gong L; Huang D; Shi Y; Liang Z; Bu H
Chin Med J (Engl); 2023 Mar; 136(6):653-665. PubMed ID: 35950752
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapy for non-small-cell lung cancer: New insights into regulated cell death combined with immunotherapy.
Li S; Wang A; Wu Y; He S; Shuai W; Zhao M; Zhu Y; Hu X; Luo Y; Wang G
Immunol Rev; 2024 Jan; 321(1):300-334. PubMed ID: 37688394
[TBL] [Abstract][Full Text] [Related]
13. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
14. Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer.
Wu J; Ye J; Xie Q; Liu B; Liu M
J Med Chem; 2022 Feb; 65(4):2989-3001. PubMed ID: 35130435
[TBL] [Abstract][Full Text] [Related]
15. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
Ryter SW
Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
[TBL] [Abstract][Full Text] [Related]
16. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis: the emerging player in remodeling triple-negative breast cancer.
Li J; He D; Li S; Xiao J; Zhu Z
Front Immunol; 2023; 14():1284057. PubMed ID: 37928550
[TBL] [Abstract][Full Text] [Related]
18. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
19. Regulated cell death pathways in cardiomyopathy.
Sheng SY; Li JM; Hu XY; Wang Y
Acta Pharmacol Sin; 2023 Aug; 44(8):1521-1535. PubMed ID: 36914852
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism.
Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S
Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
